HEPACAM and prostate cancer: HOTAIR depletion regenerated hepaCAM levels in the cells and restricted cancer growth and metastasis, indicating HOTAIR/hepaCAM/MAPK axis to be a potential therapeutic roadway for prostate cancer (Li et al., 2021a).